痤疮治疗市场规模、份额和增长分析（按产品、给药途径、年龄组、分销渠道和地区）- 2025-2032 年行业预测

2023 年痤疮治疗市场规模价值为 116.2 亿美元，预计将从 2024 年的 122.1 亿美元增长到 2032 年的 181.8 亿美元，预测期内（2025-2032 年）的复合年增长率为 5.1%。

由于寻常性痤疮（一种影响全球约 9.4% 人口的疾病）的盛行率不断上升，尤其是在青少年群体中，全球痤疮治疗市场预计将出现显着增长。造成这一趋势的因素包括越来越久坐的生活方式、不良的饮食习惯以及越来越偏好微创的美容疗程。光是在美国，每年就有 5000 万人面临这种皮肤问题，其中 90% 的男性和 80% 的女性在一生中的某个时刻都会经历痤疮。然而，对抗生素和类视色素 A等治疗药物的安全性问题对市场扩张构成了挑战。解决这些问题并满足不断增长的需求对于未来的市场相关人员来说可能至关重要。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 资料和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 案例研究
• 监管格局
• 客户和购买标准分析
• Start-Ups分析
• 专利分析

痤疮治疗市场规模（按产品和复合年增长率） (2025-2032)

• 市场概况
• 类视色素
• 抗生素
• 异维他命A酸
• 其他的

痤疮治疗市场规模（按给药途径和复合年增长率） (2025-2032)

• 市场概况
• 口服
• 局部的

痤疮治疗市场规模（按年龄组别划分）及复合年增长率（2025-2032 年）

• 市场概况
• 10 至 17 岁
• 18 至 44 岁
• 45 至 64 岁
• 年龄 65 岁或以上

痤疮治疗市场规模（按分销管道和复合年增长率） (2025-2032)

• 市场概况
• 医院药房
• 零售药局
• 网路药局

痤疮治疗市场规模（按地区）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分析市场份额
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Ortho Dermatologics（Bausch Health Companies Inc.）（USA）
• GSK plc（UK）
• Bayer AG（Germany）
• Johnson & Johnson Services, Inc.（USA）
• Pfizer Inc.（USA）
• AbbVie Inc.（USA）
• Teva Pharmaceutical Industries Ltd.（Israel）
• Botanix Pharmaceuticals（Australia）
• L'Oreal SA（France）
• Clinique Laboratories, LLC（USA）
• Neutrogena（USA）
• Ancalima Lifesciences Ltd.（India）
• Guthy-Renker（USA）
• Murad, Inc.（USA）
• Kose Corporation（Japan）
• Nestle Skin Health（Switzerland）
• Sun Pharmaceutical Industries Ltd.（India）
• Mylan NV（USA）

结论和建议

Acne Treatment Market size was valued at USD 11.62 billion in 2023 and is poised to grow from USD 12.21 billion in 2024 to USD 18.18 billion by 2032, growing at a CAGR of 5.1% during the forecast period (2025-2032).

The global acne treatment market is poised for significant growth, driven by the increasing prevalence of acne vulgaris-a condition that affects approximately 9.4% of the global population, particularly among adolescents. Factors contributing to this trend include a rise in sedentary lifestyles, poor dietary habits, and a growing preference for less invasive cosmetic treatments. In the U.S. alone, 50 million individuals face this skin condition annually, with 90% of men and 80% of women experiencing acne at some point in their lives. However, the market's expansion is challenged by safety concerns regarding the medications used in treatment, including antibiotics and retinoids. Addressing these concerns while capitalizing on the rising demand will be crucial for market stakeholders moving forward.

Top-down and bottom-up approaches were used to estimate and validate the size of the Acne Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Acne Treatment Market Segments Analysis

Global Acne Treatment Market is segmented by Product, Route of Administration, Age Group, Distribution Channel and region. Based on Product, the market is segmented into Retinoids, Antibiotics, Isotretinoin and Others. Based on Route of Administration, the market is segmented into Oral and Topical. Based on Age Group, the market is segmented into 10 to 17 Years, 18 to 44 Years, 45 to 64 Years and 65 Years & Above. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies and Online Pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Acne Treatment Market

The global acne treatment market is experiencing significant growth due to the increasing prevalence of skin disorders worldwide. This rise in cases is prompting more patients in regions such as North America, Europe, and Asia Pacific to seek treatment options. Additionally, the emergence of a variety of acne therapies, including retinoids, isotretinoin, and both oral and topical antibiotics, is contributing to heightened awareness of available products and treatments. As patients become more informed about their options, this growing awareness is anticipated to further propel the market's expansion, highlighting the need for effective acne treatments across different demographics.

Restraints in the Acne Treatment Market

The acne treatment market faces several challenges that hinder its growth, despite the widespread occurrence of chronic acne. Notably, a report from the National Center for Biotechnology Information (NCBI) highlights that common side effects associated with antibiotics, such as nausea, vomiting, and diarrhea, affect approximately 7% of patients using tetracyclines and 4% of those on macrolides. Additionally, the U.S. Food and Drug Administration (FDA) has raised concerns about certain over-the-counter (OTC) medications due to their potential to cause severe allergic reactions or significant irritation, further complicating the landscape for effective acne treatment options.

Market Trends of the Acne Treatment Market

The acne treatment market is experiencing a significant shift towards minimally invasive therapies as patient preferences evolve and technological advancements continue. Globally, there is a growing demand for less invasive cosmetic treatments, leading dermatologists to prioritize topical agents and combination therapies over traditional surgical options. Enhanced patient-physician communication and informed decision-making have fueled this trend, as individuals seek effective and less painful solutions for acne management. The rising availability of innovative treatment modalities-paired with improved procedural documentation-further drives the market, positioning minimally invasive techniques as the preferred choice for those seeking effective and convenient acne care.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Customer & Buying Criteria Analysis
• Startup Analysis
• Patent Analysis

Global Acne Treatment Market Size by Product & CAGR (2025-2032)

• Market Overview
• Retinoids
• Antibiotics
• Isotretinoin
• Others

Global Acne Treatment Market Size by Route of Administration & CAGR (2025-2032)

• Market Overview
• Oral
• Topical

Global Acne Treatment Market Size by Age Group & CAGR (2025-2032)

• Market Overview
• 10 to 17 Years
• 18 to 44 Years
• 45 to 64 Years
• 65 Years & Above

Global Acne Treatment Market Size by Distribution Channel & CAGR (2025-2032)

• Market Overview
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Global Acne Treatment Market Size & CAGR (2025-2032)

• North America (Product, Route of Administration, Age Group, Distribution Channel)
  • US
  • Canada
• Europe (Product, Route of Administration, Age Group, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Route of Administration, Age Group, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Route of Administration, Age Group, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Route of Administration, Age Group, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Ortho Dermatologics (Bausch Health Companies Inc.) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GSK plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson Services, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AbbVie Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Botanix Pharmaceuticals (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• L'Oreal S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Clinique Laboratories, LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neutrogena (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ancalima Lifesciences Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Guthy-Renker (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Murad, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kose Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nestle Skin Health (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sun Pharmaceutical Industries Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mylan N.V. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations